Loading...
Clinical Development of the E75 Vaccine in Breast Cancer
E75 is an immunogenic peptide derived from the human epidermal growth factor receptor 2 (HER2) protein. A large amount of preclinical work evaluated the immunogenicity of E75, after which phase I trials investigated using E75 mixed with an immunoadjuvant as a vaccine. Those studies showed the vaccin...
Na minha lista:
| Udgivet i: | Breast Care (Basel) |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
S. Karger Verlag für Medizin und Naturwissenschaften GmbH
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4881244/ https://ncbi.nlm.nih.gov/pubmed/27239173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000446097 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|